481 related articles for article (PubMed ID: 27521440)
1. Neurofilament light chain level is a weak risk factor for the development of MS.
Arrambide G; Espejo C; Eixarch H; Villar LM; Alvarez-Cermeño JC; Picón C; Kuhle J; Disanto G; Kappos L; Sastre-Garriga J; Pareto D; Simon E; Comabella M; Río J; Nos C; Tur C; Castilló J; Vidal-Jordana A; Galán I; Arévalo MJ; Auger C; Rovira A; Montalban X; Tintore M
Neurology; 2016 Sep; 87(11):1076-84. PubMed ID: 27521440
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of serum neurofilaments in patients with clinically isolated syndromes.
Dalla Costa G; Martinelli V; Sangalli F; Moiola L; Colombo B; Radaelli M; Leocani L; Furlan R; Comi G
Neurology; 2019 Feb; 92(7):e733-e741. PubMed ID: 30635483
[TBL] [Abstract][Full Text] [Related]
3. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome.
van der Vuurst de Vries RM; Wong YYM; Mescheriakova JY; van Pelt ED; Runia TF; Jafari N; Siepman TA; Melief MJ; Wierenga-Wolf AF; van Luijn MM; Samijn JP; Neuteboom RF; Hintzen RQ
Mult Scler; 2019 Jun; 25(7):958-967. PubMed ID: 29774770
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
Eur J Neurol; 2017 May; 24(5):703-712. PubMed ID: 28261960
[TBL] [Abstract][Full Text] [Related]
5. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
Peng L; Bi C; Xia D; Mao L; Qian H
Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.
Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
J Neuroinflammation; 2018 Jul; 15(1):209. PubMed ID: 30021640
[TBL] [Abstract][Full Text] [Related]
7. Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes.
Wong YYM; Bruijstens AL; Barro C; Michalak Z; Melief MJ; Wierenga AF; van Pelt ED; Neuteboom RF; Kuhle J; Hintzen RQ
Neurology; 2019 Sep; 93(10):e968-e974. PubMed ID: 31383792
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
Matute-Blanch C; Villar LM; Álvarez-Cermeño JC; Rejdak K; Evdoshenko E; Makshakov G; Nazarov V; Lapin S; Midaglia L; Vidal-Jordana A; Drulovic J; García-Merino A; Sánchez-López AJ; Havrdova E; Saiz A; Llufriu S; Alvarez-Lafuente R; Schroeder I; Zettl UK; Galimberti D; Ramió-Torrentà L; Robles R; Quintana E; Hegen H; Deisenhammer F; Río J; Tintoré M; Sánchez A; Montalban X; Comabella M
Brain; 2018 Apr; 141(4):1085-1093. PubMed ID: 29452342
[TBL] [Abstract][Full Text] [Related]
9. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
Martínez MA; Olsson B; Bau L; Matas E; Cobo Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.
Modvig S; Degn M; Roed H; Sørensen TL; Larsson HB; Langkilde AR; Frederiksen JL; Sellebjerg F
Mult Scler; 2015 Dec; 21(14):1761-70. PubMed ID: 25698172
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.
Gaetani L; Eusebi P; Mancini A; Gentili L; Borrelli A; Parnetti L; Calabresi P; Sarchielli P; Blennow K; Zetterberg H; Di Filippo M
Mult Scler Relat Disord; 2019 Oct; 35():228-232. PubMed ID: 31404762
[TBL] [Abstract][Full Text] [Related]
12. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
13. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.
Sellebjerg F; Royen L; Soelberg Sørensen P; Oturai AB; Jensen PEH
Mult Scler; 2019 Oct; 25(11):1444-1451. PubMed ID: 30113249
[TBL] [Abstract][Full Text] [Related]
15. Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
Disanto G; Adiutori R; Dobson R; Martinelli V; Dalla Costa G; Runia T; Evdoshenko E; Thouvenot E; Trojano M; Norgren N; Teunissen C; Kappos L; Giovannoni G; Kuhle J;
J Neurol Neurosurg Psychiatry; 2016 Feb; 87(2):126-9. PubMed ID: 25716934
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of CSF neurofilament light and heavy chain protein in MS.
Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
[TBL] [Abstract][Full Text] [Related]
17. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
Novakova L; Zetterberg H; Sundström P; Axelsson M; Khademi M; Gunnarsson M; Malmeström C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
Neurology; 2017 Nov; 89(22):2230-2237. PubMed ID: 29079686
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of prognostic biomarkers in optic neuritis.
Tejeda-Velarde A; Costa-Frossard L; Sainz de la Maza S; Carrasco Á; Espiño M; Picón C; Toboso I; Walo PE; Lourido D; Muriel A; Álvarez-Cermeño JC; Villar LM
Eur J Neurol; 2018 Apr; 25(4):614-618. PubMed ID: 29272057
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis.
Tortorella C; Direnzo V; Taurisano P; Romano R; Ruggieri M; Zoccolella S; Mastrapasqua M; Popolizio T; Blasi G; Bertolino A; Trojano M
Mult Scler; 2015 Apr; 21(4):396-401. PubMed ID: 25168208
[TBL] [Abstract][Full Text] [Related]
20. CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Khalil M; Enzinger C; Langkammer C; Ropele S; Mader A; Trentini A; Vane ML; Wallner-Blazek M; Bachmaier G; Archelos JJ; Koel-Simmelink MJ; Blankenstein MA; Fuchs S; Fazekas F; Teunissen CE
Mult Scler; 2013 Apr; 19(4):436-42. PubMed ID: 22917689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
